Page 65 - Use Authorization News Today

The DePlatforming of Robert Kennedy Jr RFK, Jr. Responds to Instagram’s Removal of His Account RFK, Jr.’s Instagram account was deplatformed Wednesday. Dozens of media outlets reported the censorship, saying the account was removed over “vaccine misinformation,” a characterization Kennedy unequivocally rejected. By Childrens Health Defense Team Wednesday, Robert F. Kennedy, Jr.’s Instagram account was deplatformed without advanced notice. Dozens of media outlets reporting on this cen...

Credit: (AP Photo/Ted Shaffrey) Jan. 20, 2021: Moderna COVID-19 vaccine being administered at International High School in Paterson, the city’s walk-in site which on that day drew several hundred people, some of whom had lined up at 4:30 a.m. Two months into New Jersey’s COVID-19 vaccination program, more than 1 million shots have been administered and some 242,000 people have received the two doses needed to provide maximum protection. The program first targeted health care workers and lon...

Share: Usana Health Sciences (NYSE: USNA) shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued fiscal year 2021 EPS and sales guidance above estimates. The company also announced a $150 million buyback. Usana Health Sciences is a U.S.-based company engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. Usana Health Sciences shares were trading up 10.20% at $96.05 at the time of publication....

February 10, 2021 Etesevimab (JS016) Administered with Bamlanivimab Receives FDA Emergency Use Authorization for COVID-19 GlobeNewswire February 10, 2021 Etesevimab and bamlanivimab administered together is authorized for treatment of recently diagnosed, mild to moderate COVID-19 in patients who are high risk for progression to severe COVID-19 More than 250,000 doses manufactured throughout Q1 2021; up to 1 million doses by mid-2021 FDA authorizes shortened infusion time for this neutralizing a...

To embed, copy and paste the code into your website or blog: Encouraging signs continue in the COVID-19 response, as the federal government looks to fine-tune the vaccine distribution process and additional vaccine options seem poised to enter the market. More People Vaccinated Than the Number of Infected As of yesterday, 27.9 million Americans had received at least one dose of the Pfizer or Moderna vaccine. This passes the total number of COVID-19 cases in the United States, which is 26.5 mill...

Johnson & Johnson asks FDA for single-shot COVID-19 vaccine EUA Johnson & Johnson has applied for a COVID-19 Emergency Use Authorization (EUA) from the FDA, the company announced on Thursday, February 4. The application pertains to J&J’s Janssen COVID-19 vaccine candidate, a single-shot product that is ready to be shipped to distributors ‘immediately following authorization,’ Johnson & Johnson said. On January 29, Johnson & Johnson announced that its single-shot COVID-19 vaccine is 66-per...

Regeneron Reports Fourth Quarter and Full Year 2020 Financial and Operating Results News provided by Share this article Fourth quarter 2020 revenues increased 30% to $2.42 billion versus fourth quarter 2019 (4) Fourth quarter 2020 EYLEA ® U.S. net sales increased 10% to $1.34 billion versus fourth quarter 2019 and full year 2020 EYLEA U.S. net sales increased 7% versus 2019 Fourth quarter 2020 Dupixent (2) , which are recorded by Sanofi, increased 56% to $1.17 billion versus fourth quarter 201...

Vaccines have been proven to almost eradicate deadly and debilitating diseases such as smallpox and polio.  So, one can imagine how excited and hopeful I am that we have achieved a miracle in our work to end COVID-19 pandemic – a vaccine!  Vaccine manufacturers, under Operation Warp Speed, defied the odds and have given us two safe and very effective vaccines in record time. Both the Moderna and Pfizer vaccines utilize new mRNA technology and are shown to be around 95 percent effecti...

National Institute for Health and Care Excellence (NICE) Issues Medtech Innovation Briefing on CytoSorb for Reducing Risk of Bleeding During Cardiac Surgery News provided by Share this article MONMOUTH JUNCTION, N.J., Feb. 4, 2021 /PRNewswire/ --  CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients around the world, highlights the ...

Datametrex AI (TSXV: DM) has secured further test kits for its COVID-19 testing operation. The company this morning announced that it has secured exclusive rights to sell and distribute a COVID-19 saliva kit manufactured by Wizchem in both Canada and Saudi Arabia, as well as non-exclusive rights for the United Stated, the European Union, and the United Kingdom. Labelled as the COVICHEK Saliva DNA/RNA Collection Kit, as well as the associated transport medium, the test kit has secured US FDA Eme...